CURE Pharmaceutical Licenses Cannabis Extraction Patents to Vanguard Scientific

GlobeNewswire•February 12, 2020 Vanguard Scientific builds customer trust with CUREinside™ patented methods LOS ANGELES, Feb. 12, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced a licensing and collaboration agreement with Vanguard Scientific Systems, Inc., a premier provider of equipment, systems and performance solutions servicing the botanical extraction…

Details

February 12, 2020Blog, Company News, News, twitter

Energy Fuels Applauds President Trump’s 10-Year, $1.5 Billion Plan to Establish U.S. Uranium Reserve

PR Newswire•February 11, 2020 LAKEWOOD, CO, Feb. 11, 2020 /PRNewswire/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading uranium producer in the U.S., applauds President Trump for yesterday announcing a budget that seeks $150 million per year over the next 10 years (totaling $1.5 billion over that…

Details

February 11, 2020Blog, Company News, News, twitter

CURE Pharmaceutical Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery

GlobeNewswire•February 5, 2020 CURE debuts “CUREinside” quality mark on the packaging of ReLeaf Europe’s sublingual tinctures and new topical cream product lines OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing agreement with ReLeaf Europe, one of…

Details

February 5, 2020Blog, Company News, News, twitter

CURE Pharmaceutical Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors

Industry veteran brings 40 year of experience to support CURE’s rapid growth OXNARD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA, ICD.D to its board of directors. Bell brings more than 40 years of experience…

Details

November 19, 2019Blog, Company News, News, twitter

CURE Pharmaceutical Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension

GlobeNewswire•November 14, 2019 OXNARD, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR) (“CURE”), an innovative drug delivery and development company, today announced that it purchased a $200,000 convertible promissory note issued by Coeptis Pharmaceuticals, Inc., a biopharmaceutical company engaged in the acquisition, development and commercialization of branded 505(b)(2) pharmaceutical products. This note represents…

Details

November 14, 2019Blog, Company News, News, twitter

CURE Pharmaceutical Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions

GlobeNewswire•October 9, 2019 Alternative dosage demand drives company’s manufacturing expansion OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line creating CUREform™ which includes CUREfilm®, one of the most advanced oral thin films on the market today.…

Details

October 9, 2019Blog, Company News, News, twitter

CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer

GlobeNewswire•October 1, 2019 Biopharma star brings extensive translational research experience as company advances its clinical indications OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, has appointed Dr. Vered Gigi as its chief scientific officer. In this role, Dr. Gigi will oversee all CURE’s research and…

Details

October 1, 2019Blog, Company News, News, twitter

CURE Pharmaceutical Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms

GlobeNewswire•August 21, 2019 OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) –– CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp grower Fytiko Farms. The deal gives CURE direct, guaranteed access to high-quality plant material for exclusive use in its proprietary oral thin film (OTF)…

Details

August 21, 2019Blog, Company News, News, twitter